MN

MADALYN NEWS

MCDERMOTT+ LLC · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
2
last 3 years
Filings
4
2 agencies contacted
Activity
filings by quarter
Works on

Background

Government experience
2020: Paid Intern
Rep. Madeleine Dean
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

Issues relating to the 340B Drug Pricing Program.
Medicare/Medicaid · 2024 Q4
Issues related to prescription drug competition and pricing.
Consumer Issues/Safety/Products · 2024 Q4
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Medicare/Medicaid · 2024 Q4

Clients

2024 · 2 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q4
340B HEALTH
Q4lda.gov →
2024 Q4
PATIENTS FOR AFFORDABLE DRUGS NOW
Q4lda.gov →
2024 Q3
340B HEALTH
Q3lda.gov →
2024 Q3
PATIENTS FOR AFFORDABLE DRUGS NOW
3Alda.gov →
Showing recent filings · full history on lda.gov